The majority of HIV-positive people with a statin indication by current guidelines are not receiving a statin, according to an analysis at a St. Louis HIV clinic.
In the years 2011-2013 people 45 or older acquired HIV infection at a frequency similar to that of younger people in New York City, San Francisco, and North Carolina.
At the 2017 Association of Nurses in AIDS Care (ANAC) conference, we asked HIV nurses to share a moment in which their unique perspective made a big difference in the care of a particular patient.
Mentorship is a key component helping us challenge stigma, live with HIV, and commit to a life of service. We asked some community leaders to tell us about their mentors and what they've gained from these relationships.
Mentorship is a key component helping us challenge stigma, live with HIV, and commit to a life of service. We asked some community leaders to tell us about their mentors and what they’ve gained from these relationships.
Two oral presentations and numerous posters at the 16th European AIDS Conference included new data on using dolutegravir-based dual ART (many with 3TC) as a switch option for people currently on stable three-drug ART.
Signal That ABX464 Reduces Viral Reservoir but Not Time to Viral Rebound After Treatment Interruption
New data presented at EACS 2017 suggested that the investigational REV inhibitor ABX464 might reduce the HIV viral reservoir in a study that included a treatment interruption.
We asked HIV community leaders how their priorities have changed since Trump’s election – and what they see as the most important challenges to the fight against HIV under a Trump presidency.
Jason Zucker, M.D., discusses how we can use computer algorithms to help ensure that undiagnosed people with HIV are tested, thus increasing the likelihood of them moving forward on the HIV care cascade.
Highlights of major findings on new antiretroviral therapies, including data on long-acting injectable solutions and new combination treatments packed into a single pill.